For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Compass Therapeutics Inc (NASDAQ: CMPX) closed at $2.69 in the last session, up 2.67% from day before closing price of $2.62. In other words, the price has increased by $2.67 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
We take a closer look at CMPX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 14.96 and its Current Ratio is at 14.96. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On February 19, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.
On December 23, 2024, D. Boral Capital started tracking the stock assigning a Buy rating and target price of $32.D. Boral Capital initiated its Buy rating on December 23, 2024, with a $32 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 437.62 while its Price-to-Book (P/B) ratio in mrq is 2.96.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 1.82%, while the 200-Day Moving Average is calculated to be 55.87%.
Shares Statistics:
A total of 137.82M shares are outstanding, with a floating share count of 80.70M. Insiders hold about 41.64% of the company’s shares, while institutions hold 38.87% stake in the company.
